XML 95 R77.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Schedule of Significant Components of Company's Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Assets        
Acquired in-process research and development $ 45,938 $ 42,460    
Net operating loss carryforward 6,370 29,739    
Accrued compensation 11,551 6,285    
Credits   168    
Disallowed interest   7,635    
Lease obligations, net 71 123    
Fixed assets 115 124    
Inventory 6,781 6,294    
Accrued rebates 7,118 4,564    
Research and development 8,802      
Other 15 70    
Total 86,761 97,462    
Net deferred tax asset 85,943 96,366    
Valuation allowance   (96,366) $ (102,874) $ (100,656)
Total 85,943      
Liabilities        
Other 818 1,096    
Total $ 818 $ 1,096